Psychopharmacology and Psychiatry Updates cover image

CBD in Psychiatry: Promise or Hype?

Psychopharmacology and Psychiatry Updates

00:00

Intro

This chapter explores the applications of cannabidiol (CBD) in psychiatric treatment, focusing on conditions such as social anxiety and schizophrenia. It emphasizes the importance of understanding scientific evidence and exercising caution with various CBD formulations, alongside highlights of its FDA approval for certain seizure disorders.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app